Assignee
PINETREE THERAPEUTICS INC
US·1 granted patent·4 pending applications·1 citations·filing 2017–2023
Top patents by PatentIndex Score
5 records- 0175US2022298220A1Neuropilin-1 Specific Binding Peptide, Fusion Protein Fused with Same, and Use ThereofPINETREE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0270US11548915B2Composition for overcoming resistance to EGFR-targeting agentPINETREE THERAPEUTICS INC·Filed 2017·Granted Jan 10, 2023·1 cites·14 claims
- 0357US2023257422A1Composition for overcoming resistance to egfr-targeting agentPINETREE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0455US2024101682A1Bispecific antibodies comprising an nrp1 binding domain and methods of use thereofPINETREE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0549US2023312684A1Neuropilin and angiotensin converting enzyme 2 fusion peptides for treating viral infectionsPINETREE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PINETREE THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →